Over the past few years, the tumor microenvironment has been intensively investigated, with a focus on the tumor and the host immune response, particularly from the perspective of immune checkpoint molecules, including PD-L1, PD-1 and CTLA-4 [8, 33, 34]. The gene discussed is CD274; the disease is neoplasm.